cell analysis
PerkinElmer Acquiring Nexcelom Bioscience for $260M
Nexcelom provides tools for cell counting and analysis, including automated cell counting instruments, image cytometry workstations, and assays.
The firm also exercised "buy down" rights to two workflows developed with Ginkgo Bioworks and announced changes to its board of directors.
Berkeley Lights Q1 Revenues Grow 35 Percent
Berkeley Lights beat the consensus analyst estimate on the top line and matched it on the bottom line as Q1 growth was driven by higher consumables and service revenues.
The company believes its combination of deep learning and microfluidic cell sorting could help solve diagnostic challenges and unlock new insights in molecular disease machinery.
Berkeley Lights Q4 Revenues Rise 31 Percent
The cell analysis firm beat the consensus top line Wall Street estimates for Q4 and full-year 2020, but missed on the bottom line for the year.